Designated organic active ingredient containing (doai) > Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai > Benzene ring containing > Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/649
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai > Benzene ring containing > Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain
Description: Subject matter wherein an amino nitrogen is indirectly bonded to an aryl ring system through a single carbon or through an acyclic chain.

Sub-classes under this class:

Class Number	Class Name	Patents
514/651	Ether oxygen is part of the chain	371
514/653	Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)	439
514/655	The aryl ring or aryl ring system and amino nitrogen are bonded directly to the same acylic carbon, which carbon additionally has only hydrogen or acyclic hydrocarbyl substituents bonded directly thereto	213
514/650	The aryl ring or aryl ring system is bonded directly to another ring or ring system	140
514/654	The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only	417

Patents under this class:

1 2 3 4 5 6 7 8 9 10

Patent Number	Title Of Patent	Date Issued
6441038	Treatment of fatigue, head injury and stroke	Aug. 27, 2002
6436938	Combination treatment for depression	Aug. 20, 2002
6436437	Covalent polar lipid conjugates with neurologically active compounds for targeting	Aug. 20, 2002
6426096	Anorexigenic composition	Jul. 30, 2002
6395762	Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists	May. 28, 2002
6387907	Use of serotonin agonists to alleviate disordered breathing episodes in a mammal	May. 14, 2002
6369113	Method for treating depression using optically pure (-)-bupropion	Apr. 9, 2002
6369051	Combinations of SSRI and estrogenic agents	Apr. 9, 2002
6362371	.beta.2- adrenergic receptor agonists	Mar. 26, 2002
6358944	Methods and compositions for treating generalized anxiety disorder	Mar. 19, 2002
6355685	Method of treating anxiety disorders	Mar. 12, 2002
6342533	Derivatives of (-)-venlafaxine and methods of preparing and using the same	Jan. 29, 2002
6342496	Bupropion metabolites and methods of use	Jan. 29, 2002
6337328	Bupropion metabolites and methods of use	Jan. 8, 2002
6337351	Pharmaceutical compositions and methods for use	Jan. 8, 2002
6335368	Use of alverine for reducing wrinkles	Jan. 1, 2002
6334997	Method of using deuterated calcium channel blockers	Jan. 1, 2002
6333332	Stabilized pharmaceutical compositions containing bupropion hydrochloride	Dec. 25, 2001
6331555	Treatment of platelet derived growth factor related disorders such as cancers	Dec. 18, 2001
6329399	Antifungal amine derivatives and processing for producing the same	Dec. 11, 2001
6319953	Treatment of depression and anxiety with fluoxetine and an NK-1 receptor antagonist	Nov. 20, 2001
6316469	Use of selective serotonin reuptake inhibitors for treatment of chest pain of non-cardiac origin and gastro-esophageal reflux disease	Nov. 13, 2001
6312716	Patch and method for transdermal delivery of bupropion base	Nov. 6, 2001
6310102	Pharmaceutical compositions and methods for use	Oct. 30, 2001
6310101	Treatments using venlafaxine	Oct. 30, 2001
6297290	Composition containing a nerve fiber reactivity modulating compound	Oct. 2, 2001
6294580	Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma	Sep. 25, 2001
6291532	Use of N-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss	Sep. 18, 2001
6280763	Apparatus and method for transdermal delivery of bupropion	Aug. 28, 2001
6277887	Methods for treating Parkinson's disease using optically pure (-)-bupropion	Aug. 21, 2001
6262124	Pharmaceutical compositions and methods for use	Jul. 17, 2001
6242496	Pharmaceutical composition containing bupropion hydrochloride and a stabilizer	Jun. 5, 2001
6221917	Pharmaceutical composition containing bupropion hydrochloride and a stabilizer	Apr. 24, 2001
6221887	Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists	Apr. 24, 2001
6211244	Calcium receptor-active compounds	Apr. 3, 2001
6211171	Use of antidepressants for local analgesia	Apr. 3, 2001
6207703	Methods and materials for treating and preventing inflammation of mucosal tissue	Mar. 27, 2001
6207674	Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants	Mar. 27, 2001
6204245	Treatment of narcolepsy with immunosuppressants	Mar. 20, 2001
6197827	Nicotine addiction treatment	Mar. 6, 2001
6194399	Aryldiamine derivatives useful as antibacterial agents	Feb. 27, 2001
6191133	Treatment of depression and pharmaceutical preparations therefor	Feb. 20, 2001
6191171	Para-aminomethylaryl carboxamide derivatives	Feb. 20, 2001
6184222	Treatment of conduct disorder	Feb. 6, 2001
6180677	Tyrosine-derived compounds as calcium channel antagonists	Jan. 30, 2001
6172091	1,2-Disubstituted cyclopropanes	Jan. 9, 2001
6166081	Methods and apparatus for treatment of Parkinson's disease	Dec. 26, 2000
6159971	Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist	Dec. 12, 2000
6150420	Method for enhanced brain delivery of bupropion	Nov. 21, 2000
6147072	Combination therapy for treatment of psychoses	Nov. 14, 2000